Assessment of circulating tumor DNA (ctDNA) burden and association with outcomes in metastatic gastric cancer (mGC) patients using real-world data (RWD)
Peter, Senaka A., Cristescu, Razvan, Pena, Carol Elaine, Watkins, Angela, Espenschied, Carin R., Liao, Jiemin
Published in Journal of clinical oncology (20.01.2024)
Published in Journal of clinical oncology (20.01.2024)
Get full text
Journal Article
Association between beta-catenin ( CTNNB1 ) mutations and clinical outcomes of pembrolizumab in advanced hepatocellular carcinoma (aHCC): Exploratory analyses from KEYNOTE-240
Kudo, Masatoshi, Cheng, Ann-Lii, Merle, Philippe, Ryoo, Baek-Yeol, Decaens, Thomas, Cicin, Irfan, Dajani, Olav, Al-Rajabi, Raed Moh'd Taiseer, Peron, Jean-Marie, Chan, Stephen Lam, Knox, Jennifer J., Daniele, Bruno, Suttner, Leah, Webber, Andrea L, Pena, Carol Elaine, Cristescu, Razvan, Chen, Cai, Hatogai, Ken, Siegel, Abby B., Finn, Richard S.
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Genetic predictor of severe sorafenib-induced diarrhea and hand-foot syndrome (HFS)
C. F. Quintanilha, Julia, Geyer, Susan Michelle, Wang, Jin, Etheridge, Amy, Denning, Stefanie, Racioppi, Alessandro, Hammond, Kelli, Crona, Daniel, Pena, Carol Elaine, Jacobson, Sawyer B., Abou-Alfa, Ghassan K., Innocenti, Federico
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Biomarker analysis from a Phase I study of copanlisib with expansion cohorts in solid tumors with and without PIK3CA mutations and NHL
Pena, Carol Elaine, Jeffers, Michael, Genvresse, Isabelle, Appleman, Leonard Joseph, Ramanathan, Ramesh K., Patnaik, Amita
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Association of activated BCR and PI3K pathways with responses and longer PFS to single-agent copanlisib in heavily pretreated patients with indolent and aggressive NHL
Liu, LI, Koechert, Karl, Cheng, Jie, Garcia-Vargas, Jose E., Childs, Barrett H., Dreyling, Martin H., Pena, Carol Elaine
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
RNAseq analysis of the sorafenib phase III DECISION trial in differentiated thyroid cancer (DTC): Correlation with clinical outcome
Capdevila, Jaume, Matos Garcia, Ignacio, Mancuso, Francesco M, Iglesias, Carmela, Nuciforo, Paolo, Zafon, Carles, Palmer, Hector G., Ogbah, Zighereda, Muiños, Laura, Pena, Carol Elaine, Brose, Marcia S., Schlumberger, Martin, Vivancos, Ana
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Phase II study of single-agent copanlisib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
Lenz, Georg, Hawkes, Eliza, Verhoef, Gregor, Haioun, Corinne, Thye, Lim Soon, Heo, Dae Seog, Ardeshna, Kirit, Chong, Geoffrey, Christensen, Jacob Haaber, Shi, Vivian, Lippert, Susanne, Hiemeyer, Florian, Piraino, Paolo, Pena, Carol Elaine, Buvaylo, Viktoriya, Childs, Barrett H., Gorbatchevsky, Igor, Salles, Gilles A.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
A phase 1b trial of PI3K inhibitor copanlisib (BAY 80-6946) combined with the allosteric-MEK inhibitor refametinib (BAY 86-9766) in patients with advanced cancer
Ramanathan, Ramesh K., Von Hoff, Daniel D., Eskens, Ferry, Blumenschein, George R., Richards, Donald A., Renshaw, Frank Gary, Rajagopalan, Prabhu, Kelly, Andrea, Pena, Carol Elaine, Mross, Klaus B.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Biomarker analyses and association with clinical outcomes in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib with or without erlotinib in the phase III SEARCH trial
Zhu, Andrew X., Kang, Yoon-Koo, Rosmorduc, Olivier, Evans, T.R. Jeffry, Santoro, Armando, Ross, Paul J., Gane, Edward, Vogel, Arndt, Jeffers, Michael, Meinhardt, Gerold, Pena, Carol Elaine
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Population PK modeling and exposure-response analyses of sorafenib in patients with radioactive iodine-refractory differentiated thyroid cancer (RAI-rDTC) in the phase III DECISION trial
Bastholt, Lars, Brose, Marcia S., Jarzab, Barbara, Schlumberger, Martin, Siena, Salvatore, De La Fouchardiere, Christelle, Paschke, Ralf, Deshpande, Hari Anant, Shi, Yuankai, Elisei, Rossella, Gao, Ming, Li, Lin, Prins, Klaas, Walker, Helen, Mitchell, David Y., Lettieri, John T., Molnar, Istvan, Kappeler, Christian, Pena, Carol Elaine
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article